LEGISLATIVE AND REGULATORY UPDATE
Week in Brief
HHS Reports Rise in 2017 Premiums for Certain ACA Health Plans by an Average of 25%.
WHITE HOUSE UPDATE
October 27
The Mental Health and Substance Use Disorder Parity Task Force Issues Final Report Announcing Various Actions and Recommendations Concerning Parity.
LEGISLATIVE UPDATE
October 26
Senate Finance Committee and House Ways & Means Committee Chairmen Issue Majority Staff White Paper on ACA Income Eligibility Verification.
October 27
Senate Finance Committee Chronic Care Working Group Releases Discussion Draft of Proposals to Impact Medicare Beneficiaries Living with Chronic Conditions.
October 28
CMS Releases Final Rule Updating Policies and Payment Rates Under ESRD PPS.
REGULATORY UPDATE
Department of Health and Human Services
October 24
CMS and FDA Announce Pilot Program for Parallel Review of Medical Devices Will Be Fully Extended and Implemented Indefinitely.
October 25
CMS Announces Opportunities for Clinicians to Participate in Advanced Alternative Payment Models.
October 26
CMS Announces Final FY 2014 and Preliminary FY 2016 DSH Allotments, and Final FY 2014 and Preliminary FY 2016 Institutions for Mental Diseases DSH Limits.
October 28
CMS Announces Dialysis Facility Compare Updates.
CMS Releases Final Rule Updating Policies and Payment Rates Under ESRD PPS.
Other News
October 27
GAO Releases Report Entitled VA Health Care: Process to Evaluate, Implement, and Monitor Organizational Structure Changes Needed.
UPCOMING EVENTS
Department of Health and Human Services
- FDA’s Medical Device User Fee Amendments Meeting
- Discussion on proposed recommendations for the reauthorization of the MDUFA for FYs 2018 through 2022.
- November 2| 9 a.m. ‐ 5 p.m.
FDA White Oak Campus – Building 31 Conference Center
10903 New Hampshire Avenue, Silver Spring, MD 20993
- November 2| 9 a.m. ‐ 5 p.m.
- Discussion on proposed recommendations for the reauthorization of the MDUFA for FYs 2018 through 2022.
- Meeting of the National Science Advisory Board for Biosecurity (NSABB)
- Discussions on the status of the Blue Ribbon Panel review of the 2014 variola virus incident and engagement on implementation of the Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern.
- November 4| 12 p.m. ‐ 3 p.m.
Teleconference
- November 4| 12 p.m. ‐ 3 p.m.
- Discussions on the status of the Blue Ribbon Panel review of the 2014 variola virus incident and engagement on implementation of the Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern.
For more information about this issue of Power Play: Washington Week in Review or more legislative and regulatory updates, contact the Powers Pyles Sutter & Verville Government Relations and Public Policy group at (202) 466-6550.